{"id":"https://openalex.org/W33853387","doi":null,"title":"Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.","display_name":"Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W33853387","mag":"33853387","pmid":"https://pubmed.ncbi.nlm.nih.gov/15597845"},"language":"en","primary_location":{"id":"pmid:15597845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15597845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of gynaecological oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W33853387"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113084000","display_name":"A. O. Mueck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122374","display_name":"Universit\u00e4ts Frauenklinik","ror":"https://ror.org/02veq1j93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210122374"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A O Mueck","raw_affiliation_strings":["Section of Endocrinology and Menopause, University Women's Hospital, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Endocrinology and Menopause, University Women's Hospital, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210122374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040233864","display_name":"Harald Seeger","orcid":"https://orcid.org/0000-0003-1552-7983","observed_orcids":["https://orcid.org/0000-0003-1552-7983"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Seeger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032246802","display_name":"Diethelm R. Wallwiener","orcid":"https://orcid.org/0000-0002-4635-5283","observed_orcids":["https://orcid.org/0000-0002-4635-5283"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Wallwiener","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005709222","display_name":"J. Huober","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Huober","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.516,"has_fulltext":false,"cited_by_count":12,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.66526032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"25","issue":"6","first_page":"699","last_page":"701"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-methoxyestradiol","display_name":"2-methoxyestradiol","score":1.0},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8949999809265137},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/additive-drug-effects","display_name":"additive drug effects","score":0.5490000247955322},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/estradiol-metabolites","display_name":"estradiol metabolites","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hormone-dependent-cancers","display_name":"hormone-dependent tumors","score":0.6690000295639038},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2776260442","wikidata":"https://www.wikidata.org/wiki/Q4596897","display_name":"2-Methoxyestradiol","level":3,"score":0.9575933218002319},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7759639620780945},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6562629342079163},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.584560215473175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5637614727020264},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5320340991020203},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.530020534992218},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.5263553857803345},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5010120868682861},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4554240107536316},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4421086013317108},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.3643856346607208},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34683138132095337},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32394441962242126},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3153310716152191},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20908966660499573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12033650279045105},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.11777570843696594}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077584","descriptor_name":"2-Methoxyestradiol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15597845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15597845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of gynaecological oncology","raw_type":"Journal Article"},{"id":"mag:33853387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15597845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1597172254","https://openalex.org/W1971054351","https://openalex.org/W1978427418","https://openalex.org/W2011068696","https://openalex.org/W2073713286","https://openalex.org/W2087662208","https://openalex.org/W2093274439","https://openalex.org/W2138191597","https://openalex.org/W2168375455","https://openalex.org/W2477215336","https://openalex.org/W2910503682","https://openalex.org/W3033757825","https://openalex.org/W3036337283","https://openalex.org/W3117287302"],"related_works":["https://openalex.org/W2322384900","https://openalex.org/W2090550507","https://openalex.org/W2409091450","https://openalex.org/W2310677154","https://openalex.org/W1971826391","https://openalex.org/W1557630738","https://openalex.org/W622203210","https://openalex.org/W1963723620","https://openalex.org/W2075556393","https://openalex.org/W2015946087"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"INVESTIGATION:":[2],"The":[3,174],"endogenous":[4],"estradiol":[5,148],"metabolite,":[6],"2-methoxyestradiol":[7],"(2ME),":[8],"has":[9,167],"been":[10,168],"shown":[11,169],"to":[12,135,170],"be":[13,171],"a":[14,21,58,110,153,183],"potent":[15],"inhibitor":[16],"of":[17,35,51,77,114,127,140,176],"cell":[18,65,70,108],"growth":[19],"and":[20,81,91,118,164],"strong":[22],"anti-angiogenic":[23],"substance.":[24],"We":[25],"investigated":[26],"for":[27,189],"the":[28,49,82,100,123,137,165],"first":[29],"time":[30],"whether":[31],"in":[32,43,152,157],"vitro":[33],"combinations":[34],"2ME":[36,78,115,132,177],"with":[37,74,116,159,178],"various":[38],"chemotherapeutic":[39,129],"compounds":[40],"may":[41,180],"result":[42],"an":[44],"additive":[45,112],"inhibitory":[46],"effect":[47,113],"on":[48],"proliferation":[50],"human":[52,62],"ovary":[53,63,106],"cancer":[54,64,107,163],"cells.":[55],"METHOD:":[56],"As":[57],"model":[59],"two":[60],"different":[61],"lines":[66,71,109],"were":[67,72],"used.":[68],"All":[69],"incubated":[73],"equimolar":[75],"concentrations":[76],"(0.8-25":[79],"microM)":[80],"chemotherapeutics":[83,142,179],"epirubicine,":[84],"doxorubicine,":[85],"paclitaxel,":[86],"docetaxel,":[87],"carboplatin,":[88],"vinorelbine,":[89],"5-fluorouracil":[90],"mafosfamide.":[92],"Proliferation":[93],"was":[94,120],"measured":[95],"after":[96],"four":[97],"days":[98],"using":[99],"ATP-chemosensitivity":[101],"test.":[102],"RESULTS:":[103],"For":[104],"both":[105],"significant":[111],"epirubicine":[117],"carboplatin":[119],"observed":[121],"at":[122,143],"lower":[124],"concentration":[125],"range":[126],"these":[128],"substances.":[130],"CONCLUSION:":[131],"is":[133,150],"able":[134],"enhance":[136],"antiproliferative":[138],"activity":[139],"certain":[141],"pharmacological":[144],"relevant":[145,186],"concentrations.":[146],"This":[147],"metabolite":[149],"currently":[151],"phase":[154],"II":[155],"trial":[156],"patients":[158],"refractary":[160],"metastatic":[161],"breast":[162],"tolerability":[166],"very":[172],"good.":[173],"combination":[175],"therefore":[181],"offer":[182],"new":[184],"clinically":[185],"treatment":[187],"regimen":[188],"hormone-dependent":[190],"cancer.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W33853387","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
